bacco, the leading cause of preventable death and cardiovascular disease, is incongruous with promoting health and wellness, tobacco sales in pharmacies totaled almost $5 billion in 2012.
2 At one pharmacy chain, approximately 1 in 20 customers who filled prescriptions for conditions that are exacerbated by smoking also purchased cigarettes. 3 Corporateowned pharmacies also sell cigarettes at significantly lower prices than most other types of tobacco retailers. 4 Low prices raise concern about pharmacies as a source of illegal tobacco sales to minors. In 2012, an estimated 7% of youths who smoked reported purchasing cigarettes at pharmacies in the past month. Discussion | The violation rate for tobacco sales to youths in FDA inspections at the top US pharmacies varied by chain and was highest at Walgreens. Selling tobacco to any customer, let alone to minors, is inconsistent with Walgreens's corporate image describing the chain "at the corner of happy and healthy" and the "pharmacy America trusts." Decisions of physicians and consumers about where to fill prescriptions could be informed by the degree to which pharmacies comply with minimum age-of-sale laws for tobacco. As recommended by the Campaign for TobaccoFree Kids and other public health groups, patients and health care professionals should consider the commitment of different pharmacy chains to eliminating tobacco sales and ending tobacco use. The FDA does not have authority to ban tobacco sales in pharmacies. Therefore, this research could inform public opinion about such regulation at the state and local levels. Although strong public support for tobacco-free pharmacies exists, only 4 states have adopted such local ordinances, and efforts to pass state legislation have stalled. In the absence of voluntary or legislated actions to establish tobacco-free pharmacies, corporate-owned pharmacies should better prevent tobacco sales to minors, especially given the rapid adoption of state and local policies to increase the minimum legal purchase age from 18 to 21 years. Federal and state enforcement should consider targeting pharmacy chains with higher levels of noncompliance with the minimum legal sale age.
Child Sexual Orientation and Gender Identity in the Adolescent Brain Cognitive Development Cohort Study
Sexual and gender minorities (ie, individuals who do not identify as heterosexual and those whose gender identities differ from their birth sex) experience significantly elevated physical and mental health morbidities compared with heterosexual and cisgender individuals.
1 By collecting sexual orientation and gender identity (SOGI) data in a US representative cohort of 9-to 10-year-old children, the recently released Adolescent Brain Cognitive Development (ABCD) Study 2 provides an opportunity to understand the development of health disparities and resilience by SOGI at earlier ages than previous research. Both children and parental Final model is n = 23802 owing to sporadic missingness in neighborhood-level variables, geocoding, and 2015-2017 CVS inspections. Neighborhood characteristics are scaled for ease of interpretation and model convergence; z scores were multiplied by 10 (eg, z = 0.13 is coded as 1.3), and the percentage of white individuals was divided by 10 (eg, 13% white is coded as 1.3). Nevada did not inspect any of the pharmacy chains we examined during this time period. We tested a quadratic term of year squared; it improved the fit of the model and was included in model 2. The model is not sensitive to inclusion or exclusion of the 22 CVS inspections conducted after 2014.
